Pamela Pavco
2014 - RXi Pharmaceuticals
In 2014, Pamela Pavco earned a total compensation of $564.4K as Chief Development Officer at RXi Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $63,000 |
---|---|
Option Awards | $150,480 |
Salary | $350,577 |
Other | $300 |
Total | $564,357 |
Pavco received $350.6K in salary, accounting for 62% of the total pay in 2014.
Pavco also received $63K in non-equity incentive plan, $150.5K in option awards and $300 in other compensation.
Rankings
In 2014, Pamela Pavco's compensation ranked 9,890th out of 13,032 executives tracked by ExecPay. In other words, Pavco earned more than 24.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,890 out of 13,032 | 24th |
Division Manufacturing | 3,752 out of 4,966 | 24th |
Major group Chemicals And Allied Products | 1,289 out of 1,686 | 24th |
Industry group Drugs | 1,028 out of 1,365 | 25th |
Industry Pharmaceutical Preparations | 788 out of 1,043 | 24th |
Source: SEC filing on November 4, 2016.
Pavco's colleagues
We found one more compensation record of an executive who worked with Pamela Pavco at RXi Pharmaceuticals in 2014.
2014
Geert Cauwenbergh
RXi Pharmaceuticals